Solicitation to FC community:

My business has a really solid shot at curing stage iv breast cancer but we've had a devil of a time with cold outreach to investors / angels.

We're not raising a lot - we're confident 1.5M will get us to human trials.

If you think this matters, please amplify and share.

If curing stage IV breast cancer isn't a compelling hook...

Eric has the team, persistence, and unique approach to tackle a $75b/year market opportunity (US alone).

He's facing a chicken-or-egg problem in that top tier VC's think they're a bit early too invest but need funding to complete 6-12 months of studies before beginning human trials.

“bomeek”

educator, optimist, explorer. 

atrium.academy

Meridian founders are outsiders to the pharmacy space, with an electric engineering & plasma physics background. 

This is a feature not a bug. The industry needs novel approaches. 

But they're not naive - they're partnering with UT Austin's nuclear program, have a grant from department of energy, and will soon announce partnerships with top-tier pediatric cancer foundations.